Literature DB >> 68088

Correlation of e antigen, DNA polymerase activity, and Dane particles in chronic benign and chronic active type B hepatitis infections.

M J Tong, D Stevenson, I Gordon.   

Abstract

The e determinant of hepatitis B surface antigen (HBS Ag) was found in 23 of 42 patients with chronic hepatitis B virus (HBV) infection. Presence of e antigen was associated with increases in DNA polymerase activity and in the number of circulating Dane particles. In the group with detectable e antigen, the average DNA polymerase activity was 367+/-78 counts per minute (cpm; mean+/-standard error [SE]), and the average number of Dane particles counted in electron micrographs was 4.4% of the total HBS Ag. In contrast, e antigen-negative patients had an average DNA polymerase activity of 40+/-6.9 cpm (P less than 0.1) and an average Dane particle count equal to 0.6% of the HBS Ag. The e antigen was detected in 68% of patients who were HBS Ag carriers or had persistent viral hepatitis and 40% of those with chronic active type B hepatitis. Thus, the presence of e antigen correlated with both the chronicity and presence of infectious HBV. However, it did not correlate with the type or severity of liver disease after HBV infection, since e antigen was present in both chronic benign and chronic aggressive hepatitis B infections.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 68088     DOI: 10.1093/infdis/135.6.980

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

2.  Radioimmunoassay in the detection of the hepatitis B e antigen/antibody system in asymptomatic carriers of hepatitis B surface antigen. Correlation with serum Dane particle associated DNA polymerase activity.

Authors:  G Pastore; A R Zanetti; P Ferroni; P Dentico; G Angarano; O Schiraldi
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study.

Authors:  F Fiaccadori; S David; G Faggion; N Feriani; C Ferrari; V Franco; T Giuberti; C Grutta D'Auria; G La Greca; G Magnani
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

4.  Specialty conference: Chronic hepatitis B.

Authors: 
Journal:  West J Med       Date:  1978-04

5.  Lack of supportive evidence for an autosomal recessive inheritance in chronic hepatitis B infections.

Authors:  M J Tong; J M Weiner
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

6.  Hepatitis B virus replication in patients with chronic liver diseases.

Authors:  B M Gandhi; M Irshad; S K Acharya; Y K Joshi; B N Tandon
Journal:  Gastroenterol Jpn       Date:  1990-04

7.  Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B.

Authors:  A Alberti; S Diana; A L Eddleston; R Williams
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

8.  Hepatitis B virus DNA detected in formalin-fixed liver specimens and its relation to serologic markers and histopathologic features in chronic liver disease.

Authors:  P J Rijntjes; T J Van Ditzhuijsen; A M Van Loon; U J Van Haelst; F B Bronkhorst; S H Yap
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

9.  Hepatitis B virus DNA polymerase activity and hepatitis B e antigen (HBeAg)/anti-HBe status among type B chronic liver diseases.

Authors:  S Kashiwagi; J Hayashi; H Ikematsu; H Nomura; W Kajiyama; T Shingu; K Hayashida; M Kaji
Journal:  Gastroenterol Jpn       Date:  1988-04

10.  Hepatitis B viral markers in pregnant women and newborn infants in Korea.

Authors:  Y G Ryoo; Y H Chang; G S Choi; W J Jeong; J W Kim; N K Joung; Y K Oh; B H Lee; S S Rim; Y H Kim
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.